These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21083304)

  • 1. Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics.
    Sun J; Schnackenberg LK; Hansen DK; Beger RD
    Bioanalysis; 2010 Feb; 2(2):207-16. PubMed ID: 21083304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans.
    Gopaul SV; Farrell K; Abbott FS
    J Mass Spectrom; 2000 Jun; 35(6):698-704. PubMed ID: 10862121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W; Abbott FS
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An effective assessment of valproate sodium-induced hepatotoxicity with UPLC-MS and (1)HNMR-based metabonomics approach.
    Huo T; Chen X; Lu X; Qu L; Liu Y; Cai S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():109-16. PubMed ID: 25168794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantage of LC-MS metabolomics methodology targeting hydrophilic compounds in the studies of fermented food samples.
    Yoshida H; Yamazaki J; Ozawa S; Mizukoshi T; Miyano H
    J Agric Food Chem; 2009 Feb; 57(4):1119-26. PubMed ID: 19170502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing and analysis of GC/LC-MS-based metabolomics data.
    Want E; Masson P
    Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption.
    Llorach R; Urpi-Sarda M; Jauregui O; Monagas M; Andres-Lacueva C
    J Proteome Res; 2009 Nov; 8(11):5060-8. PubMed ID: 19754154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics.
    Wei R; Li G; Seymour AB
    Anal Chem; 2010 Jul; 82(13):5527-33. PubMed ID: 20524683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of Slc27a5 gene expression followed by LC-MS measurement of bile acid reconjugation using metabolomics and a stable isotope tracer strategy.
    Castro-Perez JM; Roddy TP; Shah V; Wang SP; Ouyang X; Ogawa A; McLaren DG; Tadin-Strapps M; Robinson MJ; Bartz SR; Ason B; Chen Y; Previs SF; Wong KK; Vreeken RJ; Johns DG; Hubbard BK; Hankemeier T; Mitnaul L
    J Proteome Res; 2011 Oct; 10(10):4683-91. PubMed ID: 21819150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based metabolomics of yeast.
    Crutchfield CA; Lu W; Melamud E; Rabinowitz JD
    Methods Enzymol; 2010; 470():393-426. PubMed ID: 20946819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity determination of valproic acid in mouse plasma using semi-automated sample preparation and liquid chromatography with tandem mass spectrometric detection.
    Pucci V; Monteagudo E; Bonelli F
    Rapid Commun Mass Spectrom; 2005; 19(24):3713-8. PubMed ID: 16299698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-based metabolomics in the clinical laboratory.
    Becker S; Kortz L; Helmschrodt C; Thiery J; Ceglarek U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():68-75. PubMed ID: 22074957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of metabolomics biomarkers for early detection of nephrotoxicity.
    Boudonck KJ; Mitchell MW; Német L; Keresztes L; Nyska A; Shinar D; Rosenstock M
    Toxicol Pathol; 2009 Apr; 37(3):280-92. PubMed ID: 19380839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    Löscher W; Fisher JE; Nau H; Hönack D
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1067-78. PubMed ID: 2506334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.